Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HIV Seropositivity × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 30 Colorectal Neoplasms 25 Neoplasms 20 Ovarian Neoplasms 19 Lung Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Head and Neck Neoplasms 14 Pancreatic Neoplasms 13 Neoplasm Metastasis 13 Leukemia, Myeloid, Acute 12 Lymphoma, Non-Hodgkin 11 Glioblastoma 11 Rectal Neoplasms 10 Fallopian Tube Neoplasms 10 Esophageal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lymphoma 9 Recurrence 8 Melanoma 8 Lymphoma, Follicular 8 Leukemia 8 Central Nervous System Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Squamous Cell 7 Carcinoma, Ovarian Epithelial 7 Lymphoma, Large B-Cell, Diffuse 6 Liver Neoplasms 6

Interventions

Vincristine 1 VGX-3100 1 Tomography, X-Ray Computed 1 Spirometry 1 Rituximab 1 Prednisone 1 Etoposide 1 Electroporation Therapies 1 Electroporation 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01296113 2023-03-14

CHIVA

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡